Articles

From complex and high-sensitive substances to vaccines and biotechnologically produced proteins, production of drug products requires a high-level of expertise to cover all of the necessary processes prior to independent completion of the final product. A major challenge is the...

It’s clear that pharmaceutical industries must strive to cut costs and operate more efficiently and effectively – and the latest in new generation instrumentation and control systems can help here to unlock even more potential and sector growth, says...

Design validation is a critical regulatory requirement, which if done systematically, sets a strong foundation in the success of launching a new medical device to market, while ensuring that the device meets user needs. In the last article “Building a...

Medical device development is a long journey consisting of preliminary bench testing, multiple cycles of ‘build-test-fail-redesign’ and taking the product concept from Research and Development (R&D) to production. Other steps include analyzing the economic environment, getting through clinical trials,...

The development and introduction of new biological drug substances has been on the rise, and so have the regulatory requirements placed on these often life-saving products. At the same time, innovative analytical technologies have been developed that offer new...

Ultra high barrier films protect any dosage content The Pharmaceutical Industry has always mainly focused on novel drug research, formulation development,  and  subsequent  clinical  trials.  As  with  all  other  phases  it  presents  its  own  challenges. There is no use if...

Positron emission tomography (PET) is a popular nuclear imaging technique used to gain information about specific molecular biomarkers. It is often combined with other imaging technologies, such as magnetic resonance imaging (MRI) and computed tomography (CT) scanning, to incorporate...